News

Latest Releases

U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing

WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S.   The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals.  “Ensuring that

U.S. Senator Tina Smith Presses Postmaster General to Ensure Timely Deliveries, Safe Working Conditions Ahead of Busy Holiday Season

WASHINGTON, D.C. — Today, U.S. Senator Tina Smith (D-MN) sent a letter to U.S. Postmaster General Louis DeJoy requesting information about how the Postal Service plans to ensure on-time deliveries and safe working conditions during the holiday season. Millions of Minnesotans depend of the Postal Service to pay bills, receive prescriptions, and conduct other essential business. When service is unreliable, Minnesotans can face serious consequences – from late payment fees and social security checks to days without critical prescription medications. Smith also pushed DeJoy to ensure Postal Service employees, who are often overworked during this busy time of year, are adequately supported. “The timeliness of deliveries and safety of workers are both critical issues in Minnesota, where severe weather adds a complicated dimension to the usual peak-season delivery challenges,” wrote Senator Smith. “I urge you to take every possible precaution and preparation to protect workers and ensure timely deliveries this holiday season.” In her letter, Smith requested responses to the following questions by November 23, 2023: You can find a full copy of the letter here.

Klobuchar, Smith Join Colleagues to Introduce New Legislation to Tackle Nationwide Digital Equity Gap

WASHINGTON – U.S. Senator Amy Klobuchar (D-MN), co-chair of the bipartisan Senate Broadband Caucus, and Senator Tina Smith (D-MN) joined Senator Patty Murray (D-WA) to introduce new legislation aimed at closing the growing digital divide in communities across the country. The Digital Equity Act of 2019 creates new federal investments targeted toward a diverse array of projects at the state and local level that promote “digital equity”— a concept defined by the National Digital Inclusion Alliance as the “condition in which all individuals and communities have the information technology capacity needed for full participation in our society, democracy and economy.”

Klobuchar, Smith Join Colleagues in Calling for Full Funding of the Firefighter Cancer Registry

WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) joined Senators Bob Menendez (D-NJ), Deb Fischer (R-NE), and over 30 other senators in requesting full funding for the Firefighter Cancer Registry. The Firefighter Cancer Registry Act was signed into law in July 2018 and requires the Centers for Disease Control and Prevention (CDC) to collect the number and type of fire incidents in connection to firefighters who receive a cancer diagnosis—helping doctors and researchers to study the relationship between firefighting and an increased risk for the deadly disease. Although $2.5 million was authorized for the registry, the full

U.S. Sens. Amy Klobuchar, Tina Smith Help Introduce Bill to Make Important Investments in High-Need Schools and Special Education in Minnesota, Across Nation

WASHINGTON, D.C. [04/12/2019]—This week, U.S. Senators Amy Klobuchar and Tina Smith (D-Minn.) continued to fight for strong investments in schools across the country by helping introduce the Keep Our Promise to America’s Children and Teachers (PACT) Act, which would put the nation on the right path of funding special education and making sure every child has access to quality education.   “A high-quality education should be the basic right of every child, no matter where they live or how they learn,” said Sen. Klobuchar. “Every student deserves fair and equal access to the best education possible, and Congress has an

U.S Senator Tina Smith Introduces Bipartisan Legislation to Bring Lower-Cost Insulin to Market

WASHINGTON, D.C. [04/11/2019]—Today, U.S. Senator Tina Smith (D-Minn.) continued her push to bring down the fast-rising price of insulin by introducing a bipartisan bill with Republican Senator Bill Cassidy, M.D. (R-La.) focused on bringing lower-cost insulin to market. The Food and Drug Administration (FDA) is currently transitioning the way it regulates insulin, and Sens. Smith and Cassidy’s bill—the Protecting Access to Biosimilars Act—would codify this new pathway for insulin to come to market, thus increasing market competition and driving down the cost of the life-saving medicine. You can access a summary of the bill here.   “High insulin prices are

en_USEnglish